Dissertation > Excellent graduate degree dissertation topics show

Observing and Analyzing the Sample Diastolic Hypertension Sicker in the Treatment of the Drugs Which United the Lacidipine with the Benazepril.

Author: LuoWeiXiong
Tutor: LiZiCheng
School: Jinan University
Course: Cardiovascular
Keywords: Lacidipine Benazepril Isolated diastolic hypertension Hyperlipidemia Young and middle-aged
CLC: R544.1
Type: Master's thesis
Year: 2009
Downloads: 29
Quote: 0
Read: Download Dissertation

Abstract


Objective: To observe the of Chala Xi horizon joint benazepril isolated diastolic hypertension and mild hyperlipidemia young and middle-aged faculty of efficacy. Methods: South China Agricultural University faculty examination in mid-December 2007, 46 patients with isolated diastolic hypertension (IDH) and patients with mild hypercholesterolemia in young and middle-aged faculty, the average age of 45 ± 10 years old, and the exclusion of patients with secondary hypertension Lacidipine missionary scientific behavior lifestyle, combined with benazepril treatment. Week follow-up review of the signs of the blood pressure, heart rate, timing (8 weeks, 6 months, 12 months) review the biochemical and blood lipids. Adjust the dose based on the patient's physical examination and feel the adverse reactions observed drug antihypertensive and lipid-lowering effect and the impact of drugs on the heart rate, urinalysis, blood biochemistry and adverse reactions, the time of year. Results: (1) lacidipine joint shell under constant use of enalapril effectively reduces the IDH, the effective rate of 100%, with an average diastolic blood pressure by the DBP: 93.35 disabilities 2.22mmhg fell to a year after the DBP: 74.43 Guests 2.84 mmhg. before and after treatment was statistically significant (p lt; 0.01). Two drugs at the same time reduced to half the amount still effective antihypertensive effect (100%), half of the observation period using antihypertensive effect a smooth and long-term clinical observation found no significant adverse reactions. (2) the constant use lacidipine, average heart rate rose to 74.38 ± 4.27bpm than before mild increase in heart rate, a statistically significant difference (p lt; 0.05) before and after the clinical observation of the patient and by the beginning of 71.57 ± 3.04bpm no obvious discomfort. Reducing the use lacidipine heart rate average for the 71.57 ± 3.04bpm 71.82 ± 3.25bpm before use with no significant difference (p gt; 0.05). (3) high blood pressure before and after combination therapy in patients with blood, urine, and liver. Renal biochemical examination was no significant difference (P> 0.05). (4) when in constant use, lacidipine total of three cases of adverse reactions (6.52%), benazepril cases of suspected adverse reactions (2.17%), can be tolerated. Significantly reduced in the reduction of the use of adverse reactions. (5) lifestyle changes in patients with the prevention and treatment of high blood cholesterol (hypercholesterolemia) may have a role, with an average blood lipids dropped to a year after the beginning of 5.84 ± 0.22mmol / 1 Average lipids 5.72 ± 0.19mmol / 1. The lipids change before and after the intervention was statistically significant (p lt; 0.05). Conclusion: 1 gt; the lacidipine combined with benazepril daily dose can significantly lower blood pressure (systolic and diastolic) (P lt; 0.05). Half the amount of use of reducing simple diastolic blood pressure effect is still evident (P lt; 0.05). 2 gt; constant lacidipine a mild reflex cardiac acceleration performance, but clinical use in patients with no complaints obvious discomfort. Halve the amount of use, heart rate Reply medication before basic level. 3 gt; prolonged use of the two drugs adverse reactions are mild, the patient can be basically tolerated. 4 gt; joint use of lacidipine with benazepril IDH patients no significant effect on blood, urine, liver and kidney function, worthy of clinical use in patients with simple diastolic hypertension (IDH). 5 gt; lifestyle changes in the prevention and treatment of patients with IDH and high cholesterol (hypercholesterolemia) may have a certain role, whether there has yet to be examined because a good buck factors, clinical attention should be paid to the importance of non-drug treatment sex.

Related Dissertations

  1. Clincial Research on Xue Mai Kang Decoction on Blood Fat of Hyperlipidemia Phlegm Turbility and Blood Stasis Hyperlipidemia Patients,R259
  2. Influence of ACTH on Serum Lipid Levels and Renal Function in Rats,R692
  3. The Study on Regulating Effects and Mechanism of Laminaria Japonica on Serum Lipid of Experimental Hyperlipenmia,R285.5
  4. Protective Effect of Benazepril on Cardiac Function in Diabetic Rats,R965
  5. Experimental Study of Naoluoshuning Capsule in Treating Hyperlipidemia,R285.5
  6. ZhiHeng Granule for the Treatment of Hyperlipidemia (Gan Shen Yin Xu, Tan Yu Nei Zu) Phase Ⅱ Multi-central Clinical Trials,R259
  7. Expremion of GRP78 and CHOP in Endoplamic Retlcum of Rathemart under the Strem and the Relations to Myocardial Reasape and the Intervention of Drug on It,R544.1
  8. Wuwei Shouwu Capsules in Treatment of Hyperlipidemia (Liver-Kidney Yin Deficiency) Clinical Study,R259
  9. Studies on Disease Gene MSA2756G and Drug-metabolizing Enzymes Gene CYP2C9*3 Polymorphism in Patients with Hyperlipemia and Hypertension of Ningxia Hui Population,R969.1
  10. Influences of Dual Blockage of Rennin Angiotensin System on Renal Expression of Vascular Endothelial Growth Factor and Endostatin in Type 2 Diabetic Rats,R587.2
  11. EA Fenglong Intervention Hyperlipidemia Experimental and Clinical Study,R245
  12. Clinical Observation of Huanglian Lipid-lowering Mixture in Treating Hyperlipidemia,R259
  13. The Tcm Syndromes Research of Hyperlipidemia,R259
  14. Clinical Study on the Effect of Ping Tang Jiang Zhi Fang Treating Type 2 Diabetes Mellitus with Hyperlipidemia,R259
  15. Quince seven lipid lowering agents teabag lipids in hyperlipidemic rats adjustable Pharmacodynamics,R285.5
  16. An Clinical Ivestigation on Correlation of sFKN、TNF-α in Patients of Coronary Heart Disease and Benefical Effect of Benazepril,R541.4
  17. Su- fat soft capsule clinical study of the treatment of primary hyperlipidemia,R259
  18. The pharmacodynamic Research Shan Ge lipid-lowering Dispersible Tablets,R285.5
  19. The Clinical Features of Hyperlipidemic Acute Pancreatitis,R576
  20. Expression and Significance of MDR2 Gene in Hyperlipidemic Rats,R589.2

CLC: > Medicine, health > Internal Medicine > Heart, blood vessels ( circulatory ) disease > Abnormal blood pressure > Hypertension
© 2012 www.DissertationTopic.Net  Mobile